PARP9 and gastric cancer: Mechanistic studies indicate that PARP9 interacts with SOX6, a key regulator of tumor progression, to enhance resistance to apoptosis and DNA damage, further supporting its contribution to gastric cancer pathogenesis (Li et al., 2024).